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Male Lister hooded rats (280-340 g; Charles River, UK) were group housed on a 12 h light/dark 
cycle (lights on at 8:00) with free access to food and water. The study was conducted in 
accordance with ethical review by the Animal Welfare Ethical Review Board at the University 
of Nottingham and the Animals (Scientific Procedures) Act 1986, UK. All behavioral testing 
occurred during the animals’ light cycle. 
 
Drug preparation and administration 
Cannabidiol (STI Pharmaceuticals Ltd, UK) was suspended in 2% Tween 80 and 0.9% sterile 
saline on the day of use. Rats were injected with one of three doses of cannabidiol (5, 10, 20 
mg/kg, i.p.) or vehicle (1 mL/kg, i.p.) 30 min before undergoing auditory fear extinction (see 
below). The doses of cannabidiol used were based on our previous studies examining its effects 
on fear memory processing, anxiety-like behaviour, and cardiovascular responsivity to stress 
[Guimarães et al. 1990; Resstel et al. 2009; Stern et al. 2012]. 
  
Auditory fear conditioning and extinction 
The behavioral testing paradigm used (Figure 2A) was adapted from our previous studies 
[Stevenson et al. 2009; Fenton et al. 2014]. On Day 0, rats were habituated to two separate 
contexts (A and B; 10 min each). On Day 1, rats underwent tone habituation (five tones alone; 
30 s, 80 dB, 4 kHz, 2 min inter-trial interval (ITI)) followed by auditory fear conditioning (five 
tones co-terminating with footshock; 0.5 s, 0.5 mA, 2 min ITI) in Context A. On Day 2, rats 
received a drug injection (see above) and 30 min later were subjected to extinction training (15 
tones alone; 1 min ITI) in Context B. On Day 3, rats were tested for extinction recall (two tones 
alone, 1 min ITI) in Context B.  
  
Data Analysis 
Freezing, defined as the absence of movement except that related to respiration, served as the 
measure of learned fear. Freezing during tone-shock pairings on Day 1 and tone presentations 
on Days 2-3 was scored manually by two trained observers, one of whom was blind to drug 
treatment. Freezing was determined at 3 s intervals during tone presentations and the 
cumulative duration of freezing was calculated and expressed as a percentage of the 30 s tone. 
During extinction, the mean percentage of freezing during tones 1-5, 6-10, and 11-15 was 
calculated and used in the statistical analysis. During extinction recall, the mean percentage of 
freezing during both tones was calculated and used in the statistical analysis. Freezing during 
the 2 min period before tones were presented on Days 2 and 3 was calculated to infer contextual 
fear before extinction and extinction recall, respectively. Differences in freezing during fear 
conditioning between the groups to receive different drug treatments before extinction training 
the next day were analyzed using two-way analysis of variance (ANOVA), with dose and trial 
as between- and within- subject factors, respectively. Drug effects on tone-induced freezing 
during extinction were analyzed in the same way. The effects of drug given before extinction 
on tone-induced freezing during extinction recall the next day were analyzed using one-way 
ANOVA, with dose as the between subject factor. Drug effects on contextual fear before 
extinction and extinction recall were analyzed using two-way ANOVA, with dose and day as 
between- and within- subject factors, respectively. Freezing is presented as the mean + SEM. 
Post-hoc comparisons were conducted using the Tukey’s test. The level of significance for all 




Freezing during fear conditioning is shown in Figure 2B. Two-way ANOVA revealed no main 
effect of group (F(3,44)=0.22, P>0.05) or group x trial interaction (F(12,176)=0.42, P>0.05). This 
indicates that there were no differences in fear conditioning between the rats to receive vehicle 
(n=11), 5 mg/kg (n=10), 10 mg/kg (n=11), or 20 mg/kg (n=11) of cannabidiol before extinction 
the following day. The effects of cannabidiol on freezing in response to tone presentations 
during extinction is shown in Figure 2C. Two-way ANOVA revealed a significant dose x trial 
interaction (F(6,78)=3.99, P<0.01). Post-hoc analysis revealed that 20 mg/kg of cannabidiol 
significantly decreased freezing during the first tone block (tones 1-5), compared to 5 mg/kg 
and vehicle (P<0.05). This indicates that the highest dose of cannabidiol reduced auditory fear 
expression. Freezing in response to tone presentations during extinction recall is shown in 
Figure 2D. One-way ANOVA revealed no dose effect (F(3,39)=0.55, P>0.05), indicating that 
there were no effects of cannabidiol on extinction memory encoding. Freezing before tone 
presentations during extinction and extinction recall is shown in Figures 2E and 2F, 
respectively. Two-way ANOVA revealed a significant dose x day interaction (F(3,39)=2.92, 
P<0.05). Post-hoc analysis revealed that, compared to vehicle, freezing before tone 
presentations during extinction was significantly decreased with each dose of cannabidiol 
(P<0.01). In contrast, there were no differences between the groups in freezing before tone 
presentations during extinction recall. This indicates that, while contextual fear expression 
before extinction was reduced acutely by cannabidiol, there were no lasting drug effects on 
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